Licinio-Paixao J, Polonsky K S, Given B D, Pugh W, Ostrega D, Frank B F, Rubenstein A H
J Clin Endocrinol Metab. 1986 Aug;63(2):401-3. doi: 10.1210/jcem-63-2-401.
The validity of C-peptide as a peripheral marker of insulin secretion during different physiological conditions depends on the demonstration that C-peptide clearance is constant under these circumstances. Recently biosynthetic human C-peptide, identical in structure to pancreatic human C-peptide, became available for use in human subjects. The present study was undertaken to determine if the metabolic clearance of C-peptide was altered by ingestion of a mixed meal. Eight insulin-dependent diabetic patients received constant iv infusions of biosynthetic human C-peptide which raised the plasma C-peptide concentration to a level of 3.8 +/- 0.2 (+/- SEM) pmol/ml. The MCR of C-peptide was 4.5 +/- 0.3 ml/kg X min. After steady state levels of C-peptide had been reached, each patient consumed a 530 calorie mixed meal. The plasma glucose concentration increased from a baseline value of 104.5 +/- 4.8 mg/dl to a 336 +/- 10 mg/dl 150 min later. This change in plasma glucose was not associated with a significant alteration in the plasma C-peptide concentration and the MCR of the infused C-peptide was not affected by meal ingestion (4.5 +/- 0.3 vs. 4.3 +/- 0.3 ml/kg X min). These results therefore support the validity of using C-peptide as a marker for changes in insulin secretion after mixed meals.
在不同生理条件下,C肽作为胰岛素分泌外周标志物的有效性取决于能否证明在这些情况下C肽清除率恒定。最近,结构与胰腺人C肽相同的生物合成人C肽可用于人体研究。本研究旨在确定混合餐摄入是否会改变C肽的代谢清除率。8名胰岛素依赖型糖尿病患者接受了生物合成人C肽的持续静脉输注,使血浆C肽浓度升至3.8±0.2(±标准误)pmol/ml的水平。C肽的代谢清除率为4.5±0.3 ml/kg×min。在达到C肽稳态水平后,每位患者食用了一份530卡路里的混合餐。血浆葡萄糖浓度从基线值104.5±4.8 mg/dl在150分钟后升至336±10 mg/dl。血浆葡萄糖的这种变化与血浆C肽浓度的显著改变无关,且输注C肽的代谢清除率不受进餐影响(4.5±0.3 vs. 4.3±0.3 ml/kg×min)。因此,这些结果支持将C肽用作混合餐后胰岛素分泌变化标志物的有效性。